Stemgent and Pfizer Announce Collaboration
|
16 April 2010 |
Pfizer Posts Details About Interactions With U.S. Physicians
|
01 April 2010 |
Pfizer Signs Long-Term Agreement to Supply Prevenar 13 to The World's Poorest Countries
|
24 March 2010 |
Pfizer Discontinues A Phase 3 Study Of Figitumumab
|
12 March 2010 |
Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon
|
04 March 2010 |
Pfizer's Prevnar 13 Recommended by CDC's Advisory Committee On Immunization Practices
|
25 February 2010 |
Lilly, Merck, And Pfizer Announce the Formation of the Asian Cancer Research Group, Inc.
|
24 February 2010 |
Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness
|
09 February 2010 |
Pfizer Reports Fourth-Quarter and Full-Year 2009 Results
|
04 February 2010 |
New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas
|
28 January 2010 |
Pfizer and Strides Arcolab to Collaborate on Generic Products
|
07 January 2010 |
Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine
|
02 January 2010 |
FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations
|
21 December 2009 |
Takeda and Pfizer to Co-Promote Takeda's Actos® for the Treatment of Type 2 Diabetes in China
|
16 December 2009 |
Pfizer Extends Commitment to Help Unemployed Americans
|
11 December 2009 |
Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System
|
10 December 2009 |
Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
|
02 December 2009 |
FDA Advisory Committee Finds Data Support SPIRIVA® HandiHaler®
|
20 November 2009 |
Pfizer and Medivation Initiate Two Phase 3 Trials of Dimebon
|
04 November 2009 |
Pfizer Reports Third-Quarter 2009 Results
|
22 October 2009 |